Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Clinical trial NCT00003562 · UNKNOWN
Trial details
- NCT number
- NCT00003562
- Sponsor
- Hope Cancer Institute, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.